- Home
- EM vs TARA Comparison
EM vs TARA Comparison
Compare EM & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EM
- TARA
- Stock Information
- Founded
- EM 2017
- TARA N/A
- Country
- EM China
- TARA United States
- Employees
- EM N/A
- TARA N/A
- Industry
- EM Other Consumer Services
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EM Consumer Discretionary
- TARA Health Care
- Exchange
- EM Nasdaq
- TARA Nasdaq
- Market Cap
- EM 297.2M
- TARA 158.2M
- IPO Year
- EM 2021
- TARA N/A
- Fundamental
- Price
- EM $1.16
- TARA $5.07
- Analyst Decision
- EM Strong Buy
- TARA Strong Buy
- Analyst Count
- EM 1
- TARA 3
- Target Price
- EM $1.00
- TARA $22.67
- AVG Volume (30 Days)
- EM 1.9M
- TARA 348.2K
- Earning Date
- EM 03-27-2025
- TARA 03-12-2025
- Dividend Yield
- EM 2.29%
- TARA N/A
- EPS Growth
- EM N/A
- TARA N/A
- EPS
- EM 0.03
- TARA N/A
- Revenue
- EM $269,745,696.00
- TARA N/A
- Revenue This Year
- EM N/A
- TARA N/A
- Revenue Next Year
- EM $6.16
- TARA N/A
- P/E Ratio
- EM $35.33
- TARA N/A
- Revenue Growth
- EM N/A
- TARA N/A
- 52 Week Low
- EM $0.46
- TARA $1.60
- 52 Week High
- EM $1.18
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- EM 81.97
- TARA 52.19
- Support Level
- EM $1.11
- TARA $4.38
- Resistance Level
- EM $1.17
- TARA $4.99
- Average True Range (ATR)
- EM 0.03
- TARA 0.30
- MACD
- EM -0.00
- TARA -0.04
- Stochastic Oscillator
- EM 91.89
- TARA 59.70
About EM Smart Share Global Limited
Smart Share Global Ltd is a consumer tech company providing mobile device charging service through an extensive online and offline network in China. It provides service through power banks, placed in POIs operated by location partners, such as entertainment venues, restaurants, shopping centers, hotels, transportation hubs, and public spaces. Through the mini-programs, users rent the power banks to carry with them when use the service and can return the power banks at any of the POIs, enabled by the expansive network and powerful technologies.
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).